NCT02777073View on ClinicalTrials.gov

Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

December 1, 2016

Study Completion Date

December 31, 2016

Conditions
Type 1 Diabetes
Interventions
DRUG

Victoza

Single dose of Liraglutide

DRUG

Placebo

Single dose of generic placebo

DRUG

Dapagliflozin 10mg Tab

single dose of 10 mg dapagliflozin

Trial Locations (1)

14215

ECMC Ambulatory Center, 3rd Floor, Buffalo

All Listed Sponsors
lead

University at Buffalo

OTHER

NCT02777073 - Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes | Biotech Hunter | Biotech Hunter